These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
138 related articles for article (PubMed ID: 9252093)
1. Novel orally active iron chelators (3-hydroxypyridin-4-ones) enhance the biliary excretion of plasma non-transferrin-bound iron in rats. Zanninelli G; Choudury R; Loréal O; Guyader D; Lescoat G; Arnaud J; Verna R; Cosson B; Singh S; Hider RC; Brissot P J Hepatol; 1997 Jul; 27(1):176-84. PubMed ID: 9252093 [TBL] [Abstract][Full Text] [Related]
2. Intestinal absorption and enterohepatic cycling of biliary iron originating from plasma non-transferrin-bound iron in rats. Brissot P; Bolder U; Schteingart CD; Arnaud J; Hofmann AF Hepatology; 1997 Jun; 25(6):1457-61. PubMed ID: 9185768 [TBL] [Abstract][Full Text] [Related]
3. Biliary excretion of plasma non-transferrin-bound iron in rats: pathogenetic importance in iron-overload disorders. Brissot P; Zanninelli G; Guyader D; Zeind J; Gollan J Am J Physiol; 1994 Jul; 267(1 Pt 1):G135-42. PubMed ID: 8048526 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94. Chenoufi N; Hubert N; Loréal O; Morel I; Pasdeloup N; Cillard J; Brissot P; Lescoat G J Hepatol; 1995 Aug; 23(2):166-73. PubMed ID: 7499788 [TBL] [Abstract][Full Text] [Related]
5. Synthesis, physicochemical properties, and evaluation of N-substituted-2-alkyl-3-hydroxy-4(1H)-pyridinones. Rai BL; Dekhordi LS; Khodr H; Jin Y; Liu Z; Hider RC J Med Chem; 1998 Aug; 41(18):3347-59. PubMed ID: 9719587 [TBL] [Abstract][Full Text] [Related]
6. Multidentate pyridinones inhibit the metabolism of nontransferrin-bound iron by hepatocytes and hepatoma cells. Chua AC; Ingram HA; Raymond KN; Baker E Eur J Biochem; 2003 Apr; 270(8):1689-98. PubMed ID: 12694182 [TBL] [Abstract][Full Text] [Related]
7. Design, synthesis, and biological evaluation of aromatic ester prodrugs of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41) as orally active iron chelators. Liu ZD; Liu DY; Lu SL; Hider RC Arzneimittelforschung; 2000 May; 50(5):461-70. PubMed ID: 10858874 [TBL] [Abstract][Full Text] [Related]
8. Curcumin contributes to in vitro removal of non-transferrin bound iron by deferiprone and desferrioxamine in thalassemic plasma. Srichairatanakool S; Thephinlap C; Phisalaphong C; Porter JB; Fucharoen S Med Chem; 2007 Sep; 3(5):469-74. PubMed ID: 17897073 [TBL] [Abstract][Full Text] [Related]
9. Synthesis, physicochemical properties and biological evaluation of aromatic ester prodrugs of 1-(2'-hydroxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP102): orally active iron chelators with clinical potential. Liu ZD; Liu DY; Lu SL; Hider RC J Pharm Pharmacol; 1999 May; 51(5):555-64. PubMed ID: 10411215 [TBL] [Abstract][Full Text] [Related]
10. Metabolism and pharmacokinetics of 1-(2'-trimethylacetoxyethyl)-2-ethyl-3-hydroxypyridin-4-one (CP117) in the rat. Choudhury R; Epemolu RO; Rai BL; Hider RC; Singh S Drug Metab Dispos; 1997 Mar; 25(3):332-9. PubMed ID: 9172951 [TBL] [Abstract][Full Text] [Related]
11. Iron mobilization from transferrin and non-transferrin-bound-iron by deferiprone. Implications in the treatment of thalassemia, anemia of chronic disease, cancer and other conditions. Kontoghiorghes GJ Hemoglobin; 2006; 30(2):183-200. PubMed ID: 16798643 [TBL] [Abstract][Full Text] [Related]
12. Iron mobilization, cytoprotection, and inhibition of cell proliferation in normal and transformed rat hepatocyte cultures by the hydroxypyridinone CP411, compared to CP20: a biological and physicochemical study. Gaboriau F; Chantrel-Groussard K; Rakba N; Loyer P; Pasdeloup N; Hider RC; Brissot P; Lescoat G Biochem Pharmacol; 2004 Apr; 67(8):1479-87. PubMed ID: 15041465 [TBL] [Abstract][Full Text] [Related]
13. Effect of iron overload on the metabolism and urinary recovery of 3-hydroxypyridin-4-one chelating agents in the rat. Choudhury R; Singh S Drug Metab Dispos; 1995 Mar; 23(3):314-20. PubMed ID: 7628295 [TBL] [Abstract][Full Text] [Related]
14. Combined Iron Chelator and Antioxidant Exerted Greater Efficacy on Cardioprotection Than Monotherapy in Iron-Overloaded Rats. Wongjaikam S; Kumfu S; Khamseekaew J; Sripetchwandee J; Srichairatanakool S; Fucharoen S; Chattipakorn SC; Chattipakorn N PLoS One; 2016; 11(7):e0159414. PubMed ID: 27428732 [TBL] [Abstract][Full Text] [Related]
15. Hydrolytic and metabolic characteristics of the esters of 1-(3'-hydroxypropyl)-2-methyl-3-hydroxypyridin-4-one (CP41), potentially useful iron chelators. Liu DY; Liu ZD; Lu SL; Hider RC Pharmacol Toxicol; 2000 May; 86(5):228-33. PubMed ID: 10862505 [TBL] [Abstract][Full Text] [Related]
16. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats. Kontoghiorghes GJ; Sheppard L; Hoffbrand AV; Charalambous J; Tikerpae J; Pippard MJ J Clin Pathol; 1987 Apr; 40(4):404-8. PubMed ID: 3584483 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of catechol-O-methyltransferase (COMT) as well as tyrosine and tryptophan hydroxylase by the orally active iron chelator, 1,2-dimethyl-3-hydroxypyridin-4-one (L1, CP20), in rat brain in vivo. Waldmeier PC; Buchle AM; Steulet AF Biochem Pharmacol; 1993 Jun; 45(12):2417-24. PubMed ID: 7687131 [TBL] [Abstract][Full Text] [Related]
18. Selection of a new generation of orally active alpha-ketohydroxypyridine iron chelators intended for use in the treatment of iron overload. Kontoghiorghes GJ; Barr J; Nortey P; Sheppard L Am J Hematol; 1993 Apr; 42(4):340-9. PubMed ID: 8493983 [TBL] [Abstract][Full Text] [Related]
19. Evidence for a low Km transporter for non-transferrin-bound iron in isolated rat hepatocytes. Barisani D; Berg CL; Wessling-Resnick M; Gollan JL Am J Physiol; 1995 Oct; 269(4 Pt 1):G570-6. PubMed ID: 7485509 [TBL] [Abstract][Full Text] [Related]
20. Reversal of cardiac iron loading and dysfunction in thalassemic mice by curcuminoids. Thephinlap C; Phisalaphong C; Lailerd N; Chattipakorn N; Winichagoon P; Vadolas J; Fucharoen S; Porter JB; Srichairatanakool S Med Chem; 2011 Jan; 7(1):62-9. PubMed ID: 21235521 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]